美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA212184"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
68462-721-01 68462-721 HUMAN PRESCRIPTION DRUG Theophylline Theophylline TABLET, EXTENDED RELEASE ORAL 20210603 N/A ANDA ANDA212184 Glenmark Pharmaceuticals Inc., USA THEOPHYLLINE ANHYDROUS 300 mg/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-01)
68462-721-05 68462-721 HUMAN PRESCRIPTION DRUG Theophylline Theophylline TABLET, EXTENDED RELEASE ORAL 20210603 N/A ANDA ANDA212184 Glenmark Pharmaceuticals Inc., USA THEOPHYLLINE ANHYDROUS 300 mg/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-05)
68462-721-10 68462-721 HUMAN PRESCRIPTION DRUG Theophylline Theophylline TABLET, EXTENDED RELEASE ORAL 20210603 N/A ANDA ANDA212184 Glenmark Pharmaceuticals Inc., USA THEOPHYLLINE ANHYDROUS 300 mg/1 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-10)
68462-721-30 68462-721 HUMAN PRESCRIPTION DRUG Theophylline Theophylline TABLET, EXTENDED RELEASE ORAL 20210603 N/A ANDA ANDA212184 Glenmark Pharmaceuticals Inc., USA THEOPHYLLINE ANHYDROUS 300 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-30)
68462-722-30 68462-722 HUMAN PRESCRIPTION DRUG Theophylline Theophylline TABLET, EXTENDED RELEASE ORAL 20210603 N/A ANDA ANDA212184 Glenmark Pharmaceuticals Inc., USA THEOPHYLLINE ANHYDROUS 450 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-30)
68462-722-05 68462-722 HUMAN PRESCRIPTION DRUG Theophylline Theophylline TABLET, EXTENDED RELEASE ORAL 20210603 N/A ANDA ANDA212184 Glenmark Pharmaceuticals Inc., USA THEOPHYLLINE ANHYDROUS 450 mg/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-05)
68462-722-01 68462-722 HUMAN PRESCRIPTION DRUG Theophylline Theophylline TABLET, EXTENDED RELEASE ORAL 20210603 N/A ANDA ANDA212184 Glenmark Pharmaceuticals Inc., USA THEOPHYLLINE ANHYDROUS 450 mg/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-01)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase